Today Christian Barker is appointed EVP for the Health & Nutrition Division.
“We are ready for the next step for this division and we look for different management competencies to take us there. We will enforce our strategic focus and look at new opportunities for future growth. I am happy that Christian Barker has accepted to head up this challenge. Christian has substantial experience with identifying and developing growth opportunities and I look forward to expanding our collaboration”, says Cees de Jong, CEO.
Christian Barker joined the company in May 2012 as Corporate Vice President for Corporate Strategic Development. No decisions regarding his succession have been made at this point.
Christian Barker will replace Henrik Dalboege, who will be leaving Chr. Hansen as of 30 September 2013. Henrik Dalboege has been with the company since 2006 and from 2007 as part of the executive management.
“Henrik has a solid background within human health and industrial biotechnology and under his leadership the Health & Nutrition Division has developed from a business unit to an independent division with strong growth. Henrik has professionalized our activities in Health and Nutrition, and developed a sound platform for probiotics for dietary supplements and infant health. I would like to thank Henrik for his considerable contribution and dedication to Chr. Hansen”, says Cees de Jong, CEO.
As of today, Chr. Hansen's Executive Board consists of Cees de Jong, Klaus Pedersen, Knud Vindfeldt, Carsten Bennike and Jesper Allentoft.
On September 4 Chr. Hansen will present an update on its long-term strategic direction at a Capital Markets Day in Copenhagen.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.